Leap Therapeutics (LPTX) PT Raised to $6 at Piper Sandler Following ASCO GI Update
Tweet Send to a Friend
Piper Sandler analyst Tyler Van Buren raised the price target on Leap Therapeutics (NASDAQ: LPTX) to $6.00 (from $5.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
